Skip to main content

Table 4 KPNA2 expression is frequently amplified in breast cancer in comparison to healthy tissue. Breast cancer subtypes and corresponding fold-changes in KPNA2 expression relative to adjacent breast tissue for datasets located in Oncomine. P-values are directly exported from Oncomine and are obtained from a two-sample t-test

From: Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets

Breast Cancer Subtype

Fold-change

P-value

Patient numbers

Overexpression Gene Rank

Study Ref

Ductal Breast Carcinoma

5.3

6.62E-18

40

Top 1%

Richardson [33]

Male Breast Carcinoma

4.7

1.84E-31

3

Top 1%

TCGA [31]

Invasive Ductal Breast Carcinoma

3.2

5.54E-47

389

Top 1%

TCGA [31]

Medullary Breast Carcinoma

2.6

1.23E-8

32

Top 7%

Curtis [28]

Invasive Ductal Breast Carcinoma

2.2

9.54E-81

1,556

Top 3%

Curtis [28]

Invasive Lobular Breast Carcinoma

2.1

1.58E-11

36

Top 4%

TCGA [31]

Ductal Breast Carcinoma In Situ

2.1

8.67E-6

11

Top 1%

Ma [10]

Breast Carcinoma

2.1

4.00E-5

14

Top 5%

Curtis [28]

Invasive Breast Carcinoma

2.1

1.99E-5

21

Top 7%

Curtis [28]